_version_ 1783747858290180096
author Amoah, G.B.
Quakyi, I.A.
Sagoe, K.W.
Ayettey-Anie, H.N.G.
Ayettey-Adamafio, M.N.B.
Ayettey Brew, R.N.A.
Newman-Nartey, M.
Nartey, N.O.
Brightson, K.T.C.
Kessie, G.
Ayettey, A.S.
Konotey-Ahulu, F.I.D.
author_facet Amoah, G.B.
Quakyi, I.A.
Sagoe, K.W.
Ayettey-Anie, H.N.G.
Ayettey-Adamafio, M.N.B.
Ayettey Brew, R.N.A.
Newman-Nartey, M.
Nartey, N.O.
Brightson, K.T.C.
Kessie, G.
Ayettey, A.S.
Konotey-Ahulu, F.I.D.
author_sort Amoah, G.B.
collection PubMed
description
format Online
Article
Text
id pubmed-8414839
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Healthcare Infection Society. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-84148392021-09-03 Re: Oral antiseptics against coronavirus: in-vitro and clinical evidence Amoah, G.B. Quakyi, I.A. Sagoe, K.W. Ayettey-Anie, H.N.G. Ayettey-Adamafio, M.N.B. Ayettey Brew, R.N.A. Newman-Nartey, M. Nartey, N.O. Brightson, K.T.C. Kessie, G. Ayettey, A.S. Konotey-Ahulu, F.I.D. J Hosp Infect Letter to the Editor The Healthcare Infection Society. Published by Elsevier Ltd. 2021-12 2021-09-03 /pmc/articles/PMC8414839/ /pubmed/34487774 http://dx.doi.org/10.1016/j.jhin.2021.08.024 Text en © 2021 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Amoah, G.B.
Quakyi, I.A.
Sagoe, K.W.
Ayettey-Anie, H.N.G.
Ayettey-Adamafio, M.N.B.
Ayettey Brew, R.N.A.
Newman-Nartey, M.
Nartey, N.O.
Brightson, K.T.C.
Kessie, G.
Ayettey, A.S.
Konotey-Ahulu, F.I.D.
Re: Oral antiseptics against coronavirus: in-vitro and clinical evidence
title Re: Oral antiseptics against coronavirus: in-vitro and clinical evidence
title_full Re: Oral antiseptics against coronavirus: in-vitro and clinical evidence
title_fullStr Re: Oral antiseptics against coronavirus: in-vitro and clinical evidence
title_full_unstemmed Re: Oral antiseptics against coronavirus: in-vitro and clinical evidence
title_short Re: Oral antiseptics against coronavirus: in-vitro and clinical evidence
title_sort re: oral antiseptics against coronavirus: in-vitro and clinical evidence
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414839/
https://www.ncbi.nlm.nih.gov/pubmed/34487774
http://dx.doi.org/10.1016/j.jhin.2021.08.024
work_keys_str_mv AT amoahgb reoralantisepticsagainstcoronavirusinvitroandclinicalevidence
AT quakyiia reoralantisepticsagainstcoronavirusinvitroandclinicalevidence
AT sagoekw reoralantisepticsagainstcoronavirusinvitroandclinicalevidence
AT ayetteyaniehng reoralantisepticsagainstcoronavirusinvitroandclinicalevidence
AT ayetteyadamafiomnb reoralantisepticsagainstcoronavirusinvitroandclinicalevidence
AT ayetteybrewrna reoralantisepticsagainstcoronavirusinvitroandclinicalevidence
AT newmannarteym reoralantisepticsagainstcoronavirusinvitroandclinicalevidence
AT narteyno reoralantisepticsagainstcoronavirusinvitroandclinicalevidence
AT brightsonktc reoralantisepticsagainstcoronavirusinvitroandclinicalevidence
AT kessieg reoralantisepticsagainstcoronavirusinvitroandclinicalevidence
AT ayetteyas reoralantisepticsagainstcoronavirusinvitroandclinicalevidence
AT konoteyahulufid reoralantisepticsagainstcoronavirusinvitroandclinicalevidence